Track Medicamen Organics Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 1.66 %
Low
23.0
High
24.5
1 Month returns: -4.29 %
Low
21.6
High
26.8
1 Year returns: -26.17 %
Low
19.1
High
38.0
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Medicamen Organics Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Medicamen Organics Ltd. Shareholding Pattern
Quarterly breakdown of Medicamen Organics Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Medicamen Organics Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Medicamen Organics Ltd.?
The current share price of Medicamen Organics Ltd. is ₹ 24.55 as of 1 Oct 2026.
What is the market capitalisation of Medicamen Organics Ltd.?
The market capitalisation of Medicamen Organics Ltd. stands at ₹ 36.53 Cr.
What is the PE ratio of Medicamen Organics Ltd.?
The Price-to-Earnings (PE) ratio of Medicamen Organics Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Medicamen Organics Ltd.?
Medicamen Organics Ltd. has a Return on Equity (ROE) of -13.66% and a Return on Capital Employed (ROCE) of -10.85% as per the latest financial reports.
What is the 52-week high and low of Medicamen Organics Ltd.?
The 52-week high of Medicamen Organics Ltd. is - and the 52-week low is -.
What is the dividend yield of Medicamen Organics Ltd.?
The dividend yield of Medicamen Organics Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Medicamen Organics Ltd.?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Medicamen Organics Ltd. shares.
What sector does Medicamen Organics Ltd. belong to?
Medicamen Organics Ltd. operates in the Healthcare sector.
What is the beta of Medicamen Organics Ltd.?
The beta of Medicamen Organics Ltd. is 0.89, indicating its price volatility relative to the broader market.
What is the RSI of Medicamen Organics Ltd.?
The 14-day Relative Strength Index (RSI) of Medicamen Organics Ltd. is 52.48, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Medicamen Organics Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Not enough talking points with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Earnings yield of -11.0% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis
What is Earnings yield (E/P)?
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Not enough talking points with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0241451.
Sep 2024
Mar 2025
Sep 2025
Mar 2026
Total Promoter
59.69
59.73
59.73
59.73
Indian Promoter
59.69
59.73
59.73
59.73
Foreign Promoter
-
-
-
-
Institutions
3.90
3.86
3.76
1.71
Mutual Funds / UTI
-
-
-
-
FI/Bank/Insurance
0.07
0.10
0.00
0.00
Govt
-
-
-
-
FII
0.14
0.07
0.07
0.07
Other Institutions
3.69
3.69
3.69
1.64
Non-Institution
36.41
36.41
36.51
38.56
Bodies Corporate
3.45
2.72
2.67
2.85
Others (incl. Retail)
No. of shareholders
32.96
356
33.69
438
33.84
488
35.71
517
Company Profile
Overview of Medicamen Organics Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Medicamen Organics Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing and distribution of a range of pharmaceutical dosages, including generic dosage in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspension, and dry powders for governments (including both state and central governments) and private institutions as contract manufacturer/third party manufacturer. Its product portfolio consists of over 84 products and comprises a range of drugs such as antibacterial, anti-diarrheal, antifungal, anti-malarial, anti-diabetic, proton pump inhibitor, antihistamine, antihypertensive drugs, anti-lipidemic drug, antiparasitic, multivitamin, multimineral and non-steroidal anti-inflammatory drug (NSAIDS). Its products are marketed across India as well as African, CIS and southeast Asian Countries, such as Congo, Benin, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan, and Kenya.
Medicamen Organics Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing and distribution of a range of pharmaceutical dosages, including generic dosage in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspension, and dry powder...
Key personnel
Mr. Lalit Gupta
Chief Financial Officer
Ms. Varsha Bansal
Company Secretary & Compliance Officer
Mr. Bal Kishan GuptaD
Executive Chairman of the Board, Managing Director